The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

Published Date: 22 Sep 2023

The US Food and Drug Administration (FDA) has approved JAK inhibitor momelotinib (Ojjaara) as the initial treatment specifically for.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Finding a clue to the origin of treatment-resistant leukemia in kids

2.

Cancer mortality continuing to decline, says report

3.

Prostate cancer mortality is significantly reduced when docetaxel is used.

4.

Recently released national data on drug use and abuse among Americans.

5.

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot